![](\"https:\/\/mms.businesswire.com\/media\/20260520316821\/en\/1340476\/5\/Surescripts_2022_Logo.jpg\"){kind=logo}
<\/a><\/a>\nSince December 2025<\/a>, providers enabled with Surescripts Prior Authorization Automation solution, that can deliver 18-second (median) approvals when all criteria are met, increased 50%, totaling 68,000 prescribers across 42 health systems. In the same time period, Surescripts Real-Time Prescription benefit saved patients $19.7 million, outpacing the total savings in 2025.<\/p> \n\u201cWhen patients no longer need to make decisions about their treatment due to cost concerns or prior authorization delays, we have made an impact on improving their care,\u201d said Frank Harvey, Chief Executive Officer for Surescripts. \u201cSurescripts is focused on innovations like automating prior authorizations and enabling visibility into benefit and price intelligence at the point of care because it means helping patients access the treatments and care they need.\u201d<\/p> \nThe latest report highlights the impact of Surescripts solutions on addressing one of the most cited challenges facing patients. According to a survey<\/a>, 87% of pharmacists and 89% of prescribers said that prior authorization requirements negatively impact health outcomes, and 49% of prescribers said prior authorization requirements often prevent them from prescribing a medication their patients need. In addition, only 55% of Americans could readily access and afford basic healthcare and prescribed medicines, a decline from 2022, according to a report<\/a>.<\/p> \n\u201cAs affordability pressures intensify for patients\u2014particularly for specialty, diabetes and obesity medications\u2014the need to meaningfully remove obstacles at the point of care has never been more critical,\u201d said Kat Thorp, Vice President, Product Innovation, Medication Access for Surescripts. \"The latest data confirms the impact of our collaboration with payers and health systems to enable automated workflows that help patients start therapy sooner and can lead to better experiences, better adherence and better outcomes.\u201d<\/p> \nImpact Report: Prescription Intelligence When and Where It\u2019s Needed<\/b><\/a><\/p> \nData Highlights:<\/b><\/p> \nPrior Authorization Automation<\/b><\/a> <\/b>automatically matches clinical data with determination criteria at the time of prescribing. Surescripts sends the data directly to the pharmacy benefit manager (PBM) for determination, which usually comes in seconds.<\/p>\n